cas 10449-07-7|| where to buy (2-Chlorophenyl)hydrazine

Nombre del producto:(2-Chlorophenyl)hydrazine

IUPAC Name:(2-chlorophenyl)hydrazine

Unidad de embalaje	Stock disponible	Precio($)
CM344513-1g	1-2 Weeks	Ǖș
CM344513-5g	3-4 Weeks	źźș
CM344513-25g	4-5 Weeks	ŔňŔ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 10449-07-7 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :10449-07-7; Fórmula molecular:C6H7ClN2; Punto de fusión:-; Código de sonrisas:NNC1=CC=CC=C1Cl; Densidad:

: Número de catálogo:CM344513; Peso molecular:142.59; Punto de ebullición:; Nº Mdl:MFCD00982023; Almacenamiento:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Setanaxib; Genkyotex SA’s Setanaxib (GKT 831) is a small molecule NOX inhibitor currently in Phase III clinical trials and a potential treatment solution for Primary Biliary Cholangitis (PBC). PBC is a chronic and progressive condition characterized by the inflammation and subsequent destruction of the small bile ducts within the liver. Setanaxib is a novel selective inhibitor of NADPH oxidase (NOX) 1 and 4 isoforms, enabling the downregulation of multiple fibrogenic and inflammatory pathways to prevent progression of liver fibrosis. The mechanism of action of setanaxib involves both anti-fibrotic and anti-inflammatory effects.